Evaluation of the ability of continuous palonosetron infusion, using a patient-controlled analgesia device, to reduce postoperative nausea and vomiting
Korean Journal of Anesthesiology 2014³â 67±Ç 2È£ p.110 ~ p.114
°Áö¿ø(Kang Ji-Won) - Incheon St. Marys Hospital Department of Anesthesiology and Pain Medicine
¹Ú¼ö°æ(Park Soo-Kyoung) - International St. Marys Hospital Department of Anesthesiology and Pain Medicine
Abstract
Background: The efficacy of palonosetron in preventing postoperative nausea and vomiting (PONV), as well as chemotherapy-induced nausea and vomiting, has already been demonstrated in multiple clinical studies. The purpose of this study was to determine whether continuous infusion of palonosetron following single injection could reduce PONV to a greater extent than single injection only of palonosetron.
Methods: In total, 132 women were enrolled in the study. All subjects were over the age of 20 years and were scheduled to undergo gynecologic laparoscopic surgery. Patients were randomly allocated into two groups. In both groups, patients received 0.075 mg of palonosetron intravenously, immediately before induction of anesthesia. In the continuous palonosetron infusion group, 0.075 mg (1.5 ml) of palonosetron was added to the patient-controlled analgesia device. In the single-injection palonosetron group, 1.5 ml of normal saline was added.
Results: The incidence of PONV 24 hours postoperatively was significantly lower in the continuous palonosetron infusion group than the single-injection palonosetron group (31.8 vs. 56.1%, P = 0.009).
Conclusions: Continuous palonosetron infusion, following single injection, reduces the incidence of PONV compared with single injection only.
Å°¿öµå
Palonosetron, Patient-controlled analgesia, Postoperative nausea and vomiting
KMID :
0356920140670020110
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
À¯È¿¼º°á°ú(Recomendation)